5-Year Results With a Retinal Prosthesis System

Patients with severe to profound RP are experiencing promising outcomes wit…

Read Article
 

@RetinaToday

Visit @RetinaToday on Twitter

Articles From This Issue


 

Innovations in Retinaland

Medical Editors’ Page

A great man once said, “The world as we have created it is a process of our thinking. It cannot be changed without changing our thinking.” Albert Einstein was …

Retina News

Combination Therapy Shows No Benefit Over Aflibercept Alone in Phase 2 AMD Trial The phase 2 CAPELLA study evaluating aflibercept (Eylea, Regeneron) coformulated with rinuc…

 
  • AMD Awareness Month
  • DME Disease Education Resource Center
  • Uveitis Resource Center
  • ZEISS OCT Angiography eNewsletter Series
  • AMD Disease Education Resource Center
  • NEWS


     

    Google AI Matches Diabetic Retinopathy Screens

    Ophthalmologists do not have to worry just yet, but data from a new machine learning study suggest c…

    Assessing Uveitis: Beyond Vitreous Haze

    The presentations of uveitis are as varied as the brands of artificial tears at your local drug stor…

    Contact Info

    Bryn Mawr Communications LLC
    1008 Upper Gulph Road, Suite 200
    Wayne, PA 19087

    Phone: 484-581-1800
    Fax: 484-581-1818

    Karen Roman
    Editor-in-Chief
    484-581-1827
    kroman@bmctoday.com

    Janet Burk
    Publisher
    214-394-3551
    jburk@bmctoday.com

    About Retina Today

    Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.